Tagged with Medicines for Europe

Global Biosimilar Market Trends 2026: Europe Under Pressure, America Awakening, Crucial Korea
Adrian van den Hoven – Director General, Medicines for Europe
The Critical Medicines Act: A Lasting Cure for Europe’s Drug Shortage Crises?
Stephan Eder – President, Medicines for Europe
Belgium’s EU Council Presidency Priorities for Healthcare & Pharma
How to Boost Europe’s Strategic Autonomy in Medicines?
Elisabeth Stampa – President, Medicines for Europe
Innovators Slam EU Pharma Overhaul while Generics Industry & Patient Groups Applaud
Theodore Tryfon – VP, ELPEN Pharmaceutical; Co-CEO, ELPEN Group
Inflation’s Impact on Medicine Supply: Challenges for the Off-Patent Industry
An EU Pharma Policy Framework for Better Access to Affordable Medicines
Medicines for Europe Leadership Team on Generics Industry COVID Response & European Pharma Reform
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here